A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

August 30, 2023

Primary Completion Date

January 15, 2025

Study Completion Date

January 15, 2025

Conditions
Rheumatoid Arthritis
Interventions
DRUG

TQH3821 tablets 200 mg

TQH3821 is a Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) inhibitor.

DRUG

TQH3821 tablets matching placebo

TQH3821 tablets matching placebo without active substance.

Trial Locations (34)

100041

Peking University Shougang Hospital, Beijing

100044

The Peking University People's Hospital, Beijing

121000

Central Hospital of Jinzhou, Jinzhou

130021

Jilin Provincial People's Hospital, Changchun

130033

China-japan Friendship Hospital of Jilin University, Changchun

150000

The First Affiliated Hospital of Harbin Medical University, Harbin

161005

The First Hospital of Qiqihar, Qiqihar

200000

Tongji Hospital, Shanghai

211100

Nanjing Drum Tower Hospital, Nanjing

215006

The First Affiliated Hospital of Soochow University, Suzhou

236804

Bozhou People's Hospital, Bozhou

264003

Yantaishan Hospital of Yantai, Yantai

274000

Heze Municipal Hospital, Heze

277100

Zaozhuang Municipal Hospital, Zaozhuang

300211

Second Hospital of Tianjin Medical University, Tianjin

315400

Yuyao People's Hospital, Yuyao

317500

Wenling First People's Hospital, Taizhou

318000

Taizhou Central Hospital Taizhou University Hospitai, Taizhou

337000

Pingxiang People's Hospital, Pingxiang

400038

The Southwest Hospital of AMU, Chongqing

410013

Xiangya Third Hospital of Central South University, Changsha

442000

Shiyan Renmin Hospital, Shiyan

450053

People's Hospital of Zhengzhou, Zhengzhou

455000

Anyang District Hospital of Puyang City, Anyang

457001

Puyang Oilfield General Hospital, Puyang

471003

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

510000

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

530016

Guangxi Zhuang Autonomous Region People's Hospital, Nanning

611130

Chengdu Fifth People's Hospital, Chengdu

650032

First Affiliated Hospital of Kunming Medical University, Kunming

710000

The First Affiliated Hospital of PLA Air Force Medical University, Xi’an

050051

Hebei Provincial People's Hospital, Shijiazhuang

046000

Heping Hospital Affiliated to Changzhi Medical College, Changzhi

030001

First Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT05849727 - A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter